ICON PLC
SWB:IJF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ICON PLC
SWB:IJF
|
IE |
|
P
|
Procept Biorobotics Corp
NASDAQ:PRCT
|
US |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
|
Image Resources NL
ASX:IMA
|
AU |
|
MegaPower Makmur Tbk PT
IDX:MPOW
|
ID |
|
Lithium Americas Corp
F:WUC
|
CA |
|
G
|
Gap Inc
F:GAP
|
US |
|
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
ZA |
|
West High Yield (WHY) Resources Ltd
XTSX:WHY
|
CA |
Intrinsic Value
Is IJF undervalued or overvalued?
See the intrinsic value estimate for 
ICON PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
IJF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with IJF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What ICON Does
ICON PLC is a contract research organization that helps drugmakers and medical device companies run clinical trials. It plans and manages studies, recruits patients, collects and analyzes trial data, and helps customers navigate the regulatory steps needed to test new treatments. The company also offers lab and data services that support drug development from early testing through late-stage trials.
- Headquarters
- Ireland IE
- Employees
- 40 100
- IPO date
- May 15, 1998
ICON has no economic moat
Sponsors can choose among several research providers for new studies, and ICON’s global reach does not prevent rivals from competing for that work. Its experience and range of services are useful, but they do not appear to lock customers in or give the company a lasting ability to charge more than alternatives.
Read the full moat analysis
Revenue & Expenses Breakdown
ICON PLC
Earnings Waterfall
ICON PLC
The intrinsic value for ICON PLC (IJF) under the Base Case is hidden EUR.
Compared with the current market price of 164.8 EUR, the stock appears hidden.